Global positron emission tomography market is being influenced by growing incidence of chronic diseases, introduction of novel technologies, advancements in radiopharmaceuticals, increasing number of imaging centres, growing geriatric population, and government initiatives.
Home>Industry Reports>Global Positron Emission Tomography Market Assessment, Opportunities and Forecast, 2017-2031F
Global positron emission tomography market is projected to witness a CAGR of 5.1% during the forecast period 2024-2031, growing from USD 1.7 billion in 2023 to USD 2.58 billion in 2031. The global positron emission tomography market is being influenced by the increasing prevalence of chronic diseases such as heart diseases, stroke, and cancer. This surge in chronic diseases is increasing the demand for advanced diagnostic tools like PET scans, known for their precision and early detection capabilities. Another important driver include technological advancements, such as increased resolution and fast scanning abilities, which enable precise imaging for complicated procedures, ultimately enhancing diagnostic precision and patient outcomes. Moreover, the introduction of hybrid PET/CT and PET/MRI systems have diversified and enhanced the effectiveness of PET scans in clinical settings, thereby propelling the growth of global positron emission tomography market.
Government initiatives and funding are also driving the global positron emission tomography market through extensive research and development (R&D), expansion in infrastructure, and reimbursement policies. Combined with increased investments and partnerships within the industry, these efforts encourage innovation and propel PET technology's evolution. Additionally, a burgeoning elderly population is increasing the demand for PET scans as age-related ailments become more prevalent. Growing recognition and acceptance of PET imaging, along with its expansion into fields like neurology and cardiology, is further solidifying its pivotal role as a diagnostic tool.
Growing Application of PET Scans
The growing scope of positron emission tomography (PET) imaging applications significantly drives the market expansion. Initially recognized for its dominance in oncology diagnostics, PET imaging now spans diverse medical domains like neurology and cardiology. With the evolution of PET technology and the development of novel radiotracers, its utility continues to grow, empowering healthcare experts to delve deeper into disease mechanisms, treatment responses, and personalized medical approaches. This increased array of applications not only elevates patient care standards, but also increases the demand for PET imaging systems, thus significantly contributing to the widespread adoption and continuous growth of the global positron emission tomography market. In addition, the device's maximized sensitivity can be used to reduce the dosage and offer faster diagnosis, which will expand the application of PET scans across the healthcare domain.
Establishment of Research Facilities
The establishment of new research facilities is a key driving factor for the global positron emission tomography market. These centers act as innovation hubs, nurturing the advancement of cutting-edge PET imaging technologies, radiotracers, and methods. They facilitate joint research endeavors, support the exploration of various medical applications, and help improve PET's effectiveness in diagnosing and tracking different conditions. These initiatives not only draw investments and collaborations, but also expedite the development of PET technology, amplifying its influence on healthcare. This process stimulates market expansion and guarantees ongoing progress in diagnostic capabilities.
For example, the establishment of The Australian National Total Body PET Facility occurred on December 12th, 2023. Marking Australia's inaugural total body PET scanner available for unrestricted research use, this facility is poised to propel progress in cancer research, neurological disorders, cardiovascular disease studies, and pharmaceutical development. Its implementation aims to minimize scanning durations and radiation exposure, thereby revolutionizing patient care standards.
Government Initiatives
Governments around the globe are proactively implementing strategies to drive the advancement of the global positron emission tomography market. These strategies involve financing research, promoting technological progress, and improving the availability of PET technology. By supporting R&D, governments encourage the evolution of PET imaging, nurturing the development of advanced imaging systems and innovative radiotracers. Moreover, initiatives to improve reimbursement policies and healthcare infrastructure play a major role in driving the adoption of PET scan. These extensive government initiatives aim to strengthen the PET market, fostering its expansion and reinforcing its essential role in contemporary diagnostic medicine.
For instance, in November 2023, as a part of the Chief Minister's Comprehensive Health Insurance Scheme, Coimbatore Medical College Hospital (CMCH) received a boost with the commissioning of a PET CT (Positron emission tomography and computed tomography) scan machine worth INR 12 crore. At the CMCH, the procedure, which would have cost INR 20,000 in private hospitals, would only cost INR 6,500 to INR 11,000, with the Chief Minister's insurance plan covering the cost.
Increasing Use of PET Scan in Oncology
The use of PET in oncology is significantly driving the global market. PET imaging's accuracy in identifying and tracking cancerous developments supports early detection, precise staging, and evaluation of treatment response. Its capacity to offer comprehensive metabolic insights into tumors aids oncologists in making informed decisions. As PET technology advances persistently and new radiotracers emerge, its role in oncology is also growing. This progression not only enhances patient results, but also substantially bolsters the global adoption and growth of PET technology.
For instance, Meilleur Technologies, Inc. unveiled a research collaboration pact with the Young Blood Institute (YBI) on exploring the application of Meilleur’s [F-18]NAV-4694, an investigative imaging agent, in positron emission tomography examinations. This device is designed to evaluate the presence of amyloid plaque within the brain. Amyloid plaques signify a prominent feature across various neurodegenerative conditions, notably Alzheimer’s disease.
Advanced Software Solutions in Positron Emission Tomography
The increasing demand for PET software solutions is acting as a driving force behind the expansion of the global positron emission tomography market. With healthcare institutions progressively depending on PET imaging for precise disease diagnosis and monitoring treatments, there's a growing requirement for advanced software that improves image processing, analysis, and interpretation. Advanced PET software enhances workflow efficiency, facilitates precise data analysis, and improves the integration of PET scans with other imaging methods. This increased demand not only enhances the effectiveness of PET technology, but also contributes to market growth by meeting the changing demands of healthcare practitioners to deliver enhanced patient care.
For example, in May 2023, Precision DL (GE HealthCare), an AI-driven image processing software, received 510(k) clearance from the Food and Drug Administration (FDA). This software is anticipated to deliver notable enhancements in contrast-to-noise ratio (CNR), precision in quantifying features, and the ability to diagnose small lesions in PET scans.
Future Market Scenario (2024-2031F)
The future of the global positron emission tomography market exhibits remarkable promise, poised for substantial expansion. Various factors are contributing to this positive projection. Advancements in PET technology, encompassing enhanced imaging resolution, faster scan speeds, and the creation of novel radiotracers are expanding PET scan applications with increased accuracy. Furthermore, the surge in chronic diseases worldwide, alongside a growing elderly population, is increasing the demand for precise diagnostic tools like PET scans. Additionally, PET's diversified usage spanning beyond oncology into segments like neurology, cardiology, and psychiatric disorders solidifies its significance in healthcare diagnostics. Collaborative endeavors between public and private sectors, reinforced by supportive government measures and improved reimbursement policies, foster market growth. Besides this, ongoing research and technological advancements are expected to position the global positron emission tomography market for notable progress and evolution in the coming years.
Report Scope
“Positron Emission Tomography Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global positron emission tomography market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
In this report, global positron emission tomography market has been segmented into the following categories:
· By Product
o Device
§ Full Ring PET Scanners
§ Partial Ring PET Scanners
o Platform/Service
o Silicon Photomultiplier (SiPM)
o Digital Photon Counters (DPC)
o Lutetium Oxyorthosilicate (LSO)
o Lutetium Yttrium Orthosilicate (LYSO)
o Others
· By Application
o Neurology
o Oncology
o Cardiovascular
o Others
· By End-user
o Hospitals
o Diagnostic & Imaging Clinics
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
Key global positron emission tomography market players are establishing strategic alliances. These partnerships among leading firms seek to combine resources, knowledge, and technologies, aiming to propel advancements in PET imaging. These collaborations focus on stimulating innovation, creating state-of-the-art PET systems, and pioneering new radiotracers. Such affiliations enable the integration of diverse strengths, fostering research and expediting the introduction of advanced PET solutions. Ultimately, these initiatives are driving the market's progression, ensuring refined diagnostic accuracy and substantially contributing to PET technology's global growth and progression.
In September 2023, Jubilant DraxImage Inc., operating as Jubilant Radiopharma, a wholly owned subsidiary of Jubilant Pharma Limited, initiated an exclusive collaboration with Cardiac Imaging, Inc. in Oakbrook Terrace, Illinois. The partnership aims to offer healthcare facilities a daily-leased rubidium solution for conducting cardiac PET scans, thereby enhancing access to cutting-edge cardiac PET imaging for patients suspected of coronary artery disease (CAD).
Key Players Operating in Global Positron Emission Tomography Market are:
· GE Healthcare
· Fujifilm Holdings Corporation
· Siemens Healthineers Corporation
· Canon Medical Systems Corporation
· Neusoft Corporation
· Shimadzu Corporation
· CMR Naviscan
· Mediso Ltd.
· Koninklijke Philips N.V.
· Yangzhou Kindsway Biotech Co. Ltd.
· Shanghai United Imaging Healthcare Co Ltd.
· Positron Corporation
Markets and Data reports answer the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global positron emission tomography market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Outlook of Global Positron Emission Tomography Market
4. Executive Summary
5. Global Positron Emission Tomography Market Outlook, 2017-2031F
5.1. Market Size & Forecast
5.1.1.Value
5.1.2.Volume
5.2. By Product
5.2.1.Device
5.2.1.1. Full Ring PET Scanners
5.2.1.2. Partial Ring PET Scanners
5.2.2.Platform/Software
5.3. By Detector
5.3.1.Silicon Photomultiplier (SiPM)
5.3.2.Digital Photon Counters (DPC)
5.3.3.Lutetium Oxyorthosilicate (LSO)
5.3.4.Lutetium Yttrium Orthosilicate (LYSO)
5.3.5.Others
5.4. By Application
5.4.1.Neurology
5.4.2.Oncology
5.4.3.Cardiovascular
5.4.4.Others
5.5. By End-user
5.5.1.Hospitals
5.5.2.Diagnostic & Imaging Clinics
5.5.3.Others
5.6. By Region
5.6.1.North America
5.6.2.Europe
5.6.3.South America
5.6.4.Asia-Pacific
5.6.5.Middle East and Africa
5.7. By Company Market Share (%), 2023
6. Global Positron Emission Tomography Market Outlook, By Region, 2017-2031F
6.1. North America*
6.1.1. By Product
6.1.1.1. Device
6.1.1.1.1. Full Ring PET Scanners
6.1.1.1.2. Partial Ring PET Scanners
6.1.1.2. Platform/Software
6.1.2. By Detector
6.1.2.1. Silicon Photomultiplier (SiPM)
6.1.2.2. Digital Photon Counters (DPC)
6.1.2.3. Lutetium Oxyorthosilicate (LSO)
6.1.2.4. Lutetium Yttrium Orthosilicate (LYSO)
6.1.2.5. Others
6.1.3. By Application
6.1.3.1. Neurology
6.1.3.2. Oncology
6.1.3.3. Cardiovascular
6.1.3.4. Others
6.1.4. By End-user
6.1.4.1. Hospitals
6.1.4.2. Diagnostic & Imaging Clinics
6.1.4.3. Others
6.1.5. United States*
6.1.5.1. By Product
6.1.5.1.1. Device
6.1.5.1.1.1. Full Ring PET Scanners
6.1.5.1.1.2. Partial Ring PET Scanners
6.1.5.1.2. Platform/Software
6.1.5.2. By Detector
6.1.5.2.1. Silicon Photomultiplier (SiPM)
6.1.5.2.2. Digital Photon Counters (DPC)
6.1.5.2.3. Lutetium Oxyorthosilicate (LSO)
6.1.5.2.4. Lutetium Yttrium Orthosilicate (LYSO)
6.1.5.2.5. Others
6.1.5.3. By Application
6.1.5.3.1. Neurology
6.1.5.3.2. Oncology
6.1.5.3.3. Cardiovascular
6.1.5.3.4. Others
6.1.5.4. By End-user
6.1.5.4.1. Hospitals
6.1.5.4.2. Diagnostic & Imaging Clinics
6.1.5.4.3. Others
6.1.6. Canada
6.1.7. Mexico
*All segments will be provided for all regions and countries covered
6.2. Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 United Kingdom
6.2.5 Russia
6.2.6 Netherlands
6.2.7 Spain
6.2.8 Turkey
6.2.9 Poland
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.4. Asia-Pacific
6.4.1. India
6.4.2. China
6.4.3. Japan
6.4.4. Australia
6.4.5. Vietnam
6.4.6. South Korea
6.4.7. Indonesia
6.4.8. Philippines
6.5. Middle East & Africa
6.5.1. Saudi Arabia
6.5.2. UAE
6.5.3. South Africa
7. Market Mapping, 2023
7.1. By Product
7.2. By Detector
7.3. By Application
7.4. By End-user
7.5. By Region
8. Macro Environment and Industry Structure
8.1. Supply Demand Analysis
8.2. Import Export Analysis
8.3. Value Chain Analysis
8.4. PESTEL Analysis
8.4.1. Political Factors
8.4.2. Economic System
8.4.3. Social Implications
8.4.4. Technological Advancements
8.4.5. Environmental Impacts
8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter’s Five Forces Analysis
8.5.1. Supplier Power
8.5.2. Buyer Power
8.5.3. Substitution Threat
8.5.4. Threat from New Entrant
8.5.5. Competitive Rivalry
9. Market Dynamics
9.1. Growth Drivers
9.2. Growth Inhibitors (Challenges and Restraints)
10. Regulatory Framework and Innovation
10.1 Clinical Trials
10.2 Patent Landscape
10.3 Regulatory Approvals
10.4 Innovations/Emerging Technologies
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1. GE Healthcare
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. Fujifilm Holdings Corporation
14.3. Siemens Healthineers Corporation
14.4. Canon Medical Systems Corporation
14.5. Neusoft Corporation
14.6. Shimadzu Corporation
14.7. CMR Naviscan
14.8. Mediso Ltd.
14.9. Koninklijke Philips N.V.
14.10. Yangzhou Kindsway Biotech Co. Ltd.
14.11. Shanghai United Imaging Healthcare Co Ltd.
14.12. Positron Corporation
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
List of Figures
Figure 1. Global Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 4. Global Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 5. Global Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 6. Global Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 7. Global Positron Emission Tomography Market Share (%), By Region, 2017-2031F
Figure 8. North America Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 11. North America Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 12. North America Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 13. North America Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 14. North America Positron Emission Tomography Market Share (%), By Country, 2017-2031F
Figure 15. United States Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 18. United States Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 19. United States Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 20. United States Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 24. Canada Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 25. Canada Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 26. Canada Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 30. Mexico Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 31. Mexico Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 36. Europe Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 37. Europe Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 38. Europe Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Positron Emission Tomography Market Share (%), By Country, 2017-2031F
Figure 40. Germany Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 43. Germany Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 44. Germany Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 45. Germany Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 46. France Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 49. France Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 50. France Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 51. France Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 55. Italy Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 56. Italy Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 57. Italy Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 61. United Kingdom Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 62. United Kingdom Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 67. Russia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 68. Russia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 69. Russia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 73. Netherlands Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 74. Netherlands Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 79. Spain Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 80. Spain Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 81. Spain Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 85. Turkey Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 86. Turkey Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 91. Poland Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 92. Poland Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 93. Poland Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 94. South America Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 97. South America Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 98. South America Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 99. South America Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 100. South America Positron Emission Tomography Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 104. Brazil Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 105. Brazil Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 110. Argentina Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 111. Argentina Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 116. Asia-Pacific Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 117. Asia-Pacific Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Positron Emission Tomography Market Share (%), By Country, 2017-2031F
Figure 120. India Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 123. India Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 124. India Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 125. India Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 126. China Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 129. China Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 130. China Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 131. China Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 135. Japan Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 136. Japan Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 137. Japan Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 141. Australia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 142. Australia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 143. Australia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 147. Vietnam Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 148. Vietnam Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 153. South Korea Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 154. South Korea Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 159. Indonesia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 160. Indonesia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 165. Philippines Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 166. Philippines Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 171. Middle East & Africa Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 172. Middle East & Africa Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Positron Emission Tomography Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 178. Saudi Arabia Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 179. Saudi Arabia Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 184. UAE Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 185. UAE Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 186. UAE Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Positron Emission Tomography Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Positron Emission Tomography Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Positron Emission Tomography Market Share (%), By Product, 2017-2031F
Figure 190. South Africa Positron Emission Tomography Market Share (%), By Detector, 2017-2031F
Figure 191. South Africa Positron Emission Tomography Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Positron Emission Tomography Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Detector Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
India fish farming market is projected to witness a CAGR of 5.40% during the forecast period FY2025-FY2032, growing from USD 21.48 billion in FY2024 to USD 32.71 billion in FY2032. ....Read More
Published on
September 2024
3,300
India mobile crusher and screener market is projected to witness a CAGR of 5.30% during the forecast period FY2025-FY2032, growing from USD 235.48 million in FY2024 to USD 355.94 million in FY2032.....Read More
Published on
September 2024
3,300
India generic drugs market is projected to witness a CAGR of 8.29% during the forecast period FY2025-FY2032, growing from USD 13.71 billion in FY2024 to USD 25.94 billion in FY2032.....Read More
Published on
September 2024
3,300
Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD 12.72 billion in FY2024 to USD 23.23 billion in FY2032. ....Read More
Published on
September 2024
3,300
Purchase Options
USD ($)
i
2,760
3,000
8%
i
4,050
4,500
10%
i
5,016
5,700
12%
i
6,970
8,200
15%
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US